RNA | MedPath Search

Found 452 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "RNA"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC

Recruiting

Conditions: Non-Small Cell Lung Cancer

First Posted Date: 2025-02-26

Last Posted Date: 2025-02-26

Lead Sponsor: Baohui Han

Target Recruit Count: 508

Registration Number: NCT06846762

Locations: 🇨🇳
Shanghai Chest Hospital, ShangHai, Shanghai, China

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

Not yet recruiting

Conditions: Metastatic Breast Cancer (MBC)

First Posted Date: 2025-02-19

Last Posted Date: 2025-05-06

Lead Sponsor: Menarini Silicon Biosystems, INC

Target Recruit Count: 187

Registration Number: NCT06833853

Locations: 🇺🇸
UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

The Effects of Diet on Small Non-coding RNA I Sperm Cells and the Possible Effects on Reproductive Success: Diet Intervention Effects on Sperm

Not Applicable

Recruiting

Conditions: Changes in SncRNA in Sperm
Male Fertility
RNA Profile

First Posted Date: 2025-02-18

Last Posted Date: 2025-02-19

Lead Sponsor: Ostergotland County Council, Sweden

Target Recruit Count: 100

Registration Number: NCT06831292

Locations: 🇸🇪
University Hospital, Linköping, Östergötland, Sweden

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Recruiting

Conditions: Micro RNA
Cardiomyopathies
Amyloidosis Cardiac
Fabry Disease
Arrhythmogenic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM)
Laminopathies
Dystrophia Myotonica
Mitochondrial Cardiomyopathy
Dilated Cardiomyopathy

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Target Recruit Count: 700

Registration Number: NCT06813443

Locations: 🇮🇹
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Emilia-Romagna/Bologna, Italy
🇮🇹
Dipartimento di Scienze Toraciche Cardiovascolari, Fondazione Policlinico Universitario A. Gemelli IRCSS di Roma, Roma, Lazio/Roma, Italy
🇮🇹
Azienda Ospedaliero-Universitaria Careggi di Firenze, Firenze, Toscana/Firenze, Italy

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Phase 1

Not yet recruiting

Conditions: Crimean-Congo Hemorrhagic Fever
Vaccine

Interventions: Biological: 10 ug HDT 321
Biological: 25ug HDT-321
Biological: 50ug HDT-321

First Posted Date: 2025-01-29

Last Posted Date: 2025-01-29

Lead Sponsor: HDT Bio

Target Recruit Count: 48

Registration Number: NCT06799013

Locations: 🇺🇸
Flourish Research San Antonio (Clinical Trials of Texas), San Antonio, Texas, United States

The Effect of Exercise Training on lncRNA Expression in Asthma

Not Applicable

Recruiting

Conditions: Rehabilitation
Pulmonary Rehabilitation
Long Noncoding RNA
Exercise
Asthma

First Posted Date: 2025-01-15

Last Posted Date: 2025-04-18

Lead Sponsor: Saglik Bilimleri Universitesi

Target Recruit Count: 84

Registration Number: NCT06776315

Locations: 🇹🇷
University of Health Sciences, Istanbul, Turkey

Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

Phase 1

Recruiting

Conditions: Radiation-Induced Xerostomia and Hyposalivation

Interventions: Biological: RXRG001
Biological: Placebo

First Posted Date: 2024-12-03

Last Posted Date: 2025-05-31

Lead Sponsor: RiboX Therapeutics Ltd.

Target Recruit Count: 42

Registration Number: NCT06714253

Locations: 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
🇺🇸
John Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸
Penn Medicine - Otorhinolaryngology - Head and Neck Surgery Perelman, Philadelphia, Pennsylvania, United States

and more 3 locations

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

Phase 2

Recruiting

Conditions: HIV
HIV Infection

Interventions: Other: ICF
Behavioral: Eligibility Assessment
Other: Demographic data
Diagnostic Test: Weight, height and BMI
Other: Vital Signs
Diagnostic Test: Medical evaluation
Diagnostic Test: Safety exam
Diagnostic Test: Pregnancy test
Diagnostic Test: Serology
Other: Randomization
Diagnostic Test: Apoptosis markers
Diagnostic Test: Cell activation markers
Diagnostic Test: Inflammation markers
Diagnostic Test: HIV-specific antibodies
Diagnostic Test: HIV viral load (RNA)
Behavioral: Codivir® Training
Drug: Dispensing Codivir®
Other: Codivir® Accounting
Drug: Antiretrovirals
Other: Concomitant medication
Other: Adverse events

First Posted Date: 2024-11-06

Last Posted Date: 2024-11-06

Lead Sponsor: Code Pharma

Target Recruit Count: 40

Registration Number: NCT06676410

Locations: 🇧🇷
RDSS Research Center, São Paulo, Brazil

The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer

Recruiting

Conditions: Ovarian Cancer

First Posted Date: 2024-10-30

Last Posted Date: 2025-04-22

Lead Sponsor: University of Utah

Target Recruit Count: 245

Registration Number: NCT06665945

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

One-step HCV RNA Testing Among SSP Participants (HOT Study)

Not Applicable

Not yet recruiting

Conditions: Testing Effect of Intervention

Interventions: Diagnostic Test: HCV RNA Rapid testing

First Posted Date: 2024-10-09

Last Posted Date: 2024-10-09

Lead Sponsor: University of Washington

Target Recruit Count: 227

Registration Number: NCT06634342